The hydrolyzed form inhibits the BCR–ABL phosphorylation and induces apoptosis in CML cells; surprisingly, the authors concluded that hydrolyzed aucubin had a better anti-leukemia effect than aucubin itself [43]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.